Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | RORC | P51449 | 13/20 | 0.40 |
| ▸ | PPARG | P37231 | 3/20 | 0.39 |
| ▸ | KMO | O15229 | 2/20 | 0.38 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.37 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.36 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31468395 | 0.89 | KDM4E (0.50) | KDM4ENPC1RAB9ASMN1; SMN2RORC | |
| SCHEMBL31468309 | 0.88 | TNK2 (0.40) | KDM4ENPC1RAB9ASMN1; SMN2RORC | |
| SCHEMBL31468298 | 0.88 | TTR (0.39) | KDM4ENPC1RAB9ASMN1; SMN2RORC | |
| Hydrochloric Acid SCHEMBL31468439 | 0.85 | TNK2 (0.37) | KDM4ENPC1RAB9ASMN1; SMN2RORC | |
| SCHEMBL31468428 | 0.85 | TNK2 (0.41) | KDM4ENPC1RAB9ASMN1; SMN2RORC | |
| SCHEMBL31468294 | 0.82 | NR1I3 (0.39) | MDM2TNK2 | |
| SCHEMBL31468420 | 0.81 | KDM4E (0.43) | KDM4ENPC1RAB9ASMN1; SMN2RORC | |
| SCHEMBL31468330 | 0.81 | RORC (0.46) | RORCPPARGKMOTNK2 | |
| SCHEMBL31468406 | 0.80 | TNK2 (0.43) | KDM4ENPC1RAB9ASMN1; SMN2RORC | |
| SCHEMBL31468429 | 0.80 | RARA (0.48) | KDM4ENPC1RAB9ASMN1; SMN2RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025064210-A1 | INHIBITORS OF BILIVERDIN REDUCTASE B (BLVRB) | BLOOD CELL TECHNOLOGIES, LLC (US) | 2025-03-27 | — | — | WO | disclosed |